Pulmoner Aspergillozisin Klinik Tipleri: Bir Klinik Spektrum Derlemesi

Year 2025, Volume: 11 Issue: 2, 308 - 313, 28.05.2025

Gizem Özçıbık Işık , Akif Turna

https://doi.org/10.53394/akd.1456605

Abstract

Aspergillus mantar türleri doğada bulunur ve insanlarda pulmoner aspergilloz hastalıklarının nedenidir. Klinik ve radyolojik olarak genel olarak dört formda görülür; bunlar aspergilloma, kronik pulmoner aspergilloz, invaziv pulmoner aspergillozis ve allerjik bronkopulmoner aspergillozistir. Ancak pulmoner aspergillus türlerinin bir arada görüldüğü örtüşme sendromları da gözden kaçırılmamalıdır. Klinik semptomlar, radyolojik görüntüleme, serum antijen ve antikor düzeyleri, vücut sıvısı kültürleri, hızlı deri antijen testleri, serum immunoglobulin düzeyleri tanıya yardımcıdır. Tedavi seçenekleri vaka bazında değerlendirilse de; antifungal tedavi, cerrahi ve kortikosteroid ajanlar ana seçeneklerdir. COVİD-19 ile ilişkili invaziv pulmoner aspergillozis, COVİD-19 enfeksiyonu ile tanımlanmıştır. Kötü klinik prognoz nedeniyle COVİD-19 hastalarında gözden kaçırılmamalıdır.

Keywords

aspergillozis, göğüs cerrahisi, covid-19, tedavi

Clinical Types of Pulmonary Aspergillosis: A Clinical Spectrum Review

Abstract

Aspergillus fungal species are found in nature and are the cause of pulmonary aspergillosis diseases in humans. It is generally seen in four forms clinically and radiologically, these are aspergilloma, chronic pulmonary aspergillosis, invasive pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. However, overlap syndromes in which types of pulmonary aspergillosis are seen together should not be overlooked. Clinical symptoms, radiological imaging, serum antigen and antibody levels, body fluid cultures, rapid skin antigen tests, serum immunoglobulin levels are helpful for diagnosis. Although treatment options are evaluated on a case-by-case basis; antifungal therapy, surgery and corticosteroid agents are the main options. Invasive pulmonary aspergillosis associated with COVID-19 has been observed in association with COVID-19 infection. It should not be missed in patients with COVID-19 due to poor clinical prognosis.

Keywords

aspergillosis, thoracic surgery, covid-19, treatment

References

• 1. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121(6):1988-99.
• 2. Patterson KC, Strek ME. Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest 2014; 146(5):1358-68.
• 3. Danner BC, Didilis V, Dörge H, Mikroulis D, Bougioukas G, Schöndube FA. Surgical treatment of pulmonary aspergillosis/mycosis in immunocompromised patients. Interact Cardiovasc Thorac Surg 2008; 7(5):771-6.
• 4. Ichinose J, Kohno T, Fujimori S. Video-assisted thoracic surgery for pulmonary aspergilloma. Interact Cardiovasc Thorac Surg 2010; 10(6):927-30.
• 5. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011; 20(121):156-74.
• 6. Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thora. 2015; 70(3):270-77.
• 7. Kanj A, Abdallah N, Soubani AO. The spectrum of pulmonary aspergillosis. Respir Med 2018; 141:121-31.
• 8. Harmouchi H, Sani R, Issoufou I, Lakranbi M, Ouadnouni Y, Smahi M. Pulmonary aspergilloma: from classification to management. Asian Cardiovasc Thorac Ann 2020; 28(1):33-8.
• 9. Shen C, Qiao G, Wang C, Jin F, Zhang Y. Outcomes of surgery for different types of chronic pulmonary aspergillosis: results from a single-center, retrospective cohort study. BMC Pulm Med 2022; 22(1):40.
• 10. Patel DC, Bhandari P, Epstein DJ, Liou DZ, Backhus LM, Berry MF, Shrager JB, Lui NS. Surgical resection for patients with pulmonary aspergillosis in the national inpatient sample. J Thorac Dis 2021; 13(8):4977-87.
• 11. Bongomin F, Olum R, Kwizera R, Baluku JB. Surgical management of chronic pulmonary aspergillosis in Africa: A systematic review of 891 cases. Mycoses 2021; 64(10):1151-8.
• 12. Bulpa P, Duplaquet F, Dimopoulos G, Vogelaers D, Blot S. Invasive Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease Exacerbations. Semin Respir Crit Care Med 2020; 41(6):851-61.
• 13. Ledoux MP, Guffroy B, Nivoix Y, Simand C, Herbrecht R. Invasive Pulmonary Aspergillosis. Semin Respir Crit Care Med 2020; 41(1):80-98.
• 14. Lai CC, Yu WL. COVID-19 associated with pulmonary aspergillosis: A literature review. J Microbiol Immunol Infect 2021; 54(1):46-53.
• 15. Armstrong-James D, Youngs J, Bicanic T, Abdolrasouli A, Denning DW, Johnson E, Mehra V, Pagliuca T, Patel B, Rhodes J, Schelenz S, Shah A, van de Veerdonk FL, Verweij PE, White PL, Fisher MC.Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Eur Respir J 2020; 56(4):2002554.
• 16. Lackner N, Thomé C, Öfner D, Joannidis M, Mayerhöfer T, Arora R, Samardzic E, Posch W, Breitkopf R, Lass-Flörl C. COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility. J Fungi (Basel) 2022; 8(2):93.